Vanguard Fiduciary Trust
ROIV icon

Vanguard Fiduciary Trust’s Roivant Sciences ROIV Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
2,900,533
+89,412
+3% +$2.64M 0.02% 532
2026
Q1 		$77.9M Buy
+2,811,121
New +$72.2M 0.02% 614

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Fiduciary Trust's ROIV Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Roivant Sciences (ROIV) stake by 3.2% in Q2 2026, buying an estimated $2.64M and bringing the position to 2,900,533 shares worth $103M. The position accounts for 0.02% of the portfolio, ranked #532.

Vanguard Fiduciary Trust first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 496 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vanguard Fiduciary Trust held 2,900,533 shares of Roivant Sciences worth $103M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 89,412 Roivant Sciences shares in Q2 2026, an estimated $2.64M.
  • Roivant Sciences made up 0.02% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #532 holding.
  • Vanguard Fiduciary Trust first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 496 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.